Live Breaking News & Updates on Applying Evidence

Stay updated with breaking news from Applying evidence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Closing Thoughts on Advanced HCC and Highlights from ASCO GI 2023

Closing out this discussion, experts share their final thoughts on advanced HCC treatments and key data presented at the 2023 ASCO Gastrointestinal Cancers Symposium. ....

Transforming Outcomes , Hepatocellular Carcinoma , Expert Insights , Applying Evidence , Intermediate Stage , Systemic Therapy , Bclc Stage B , Patient Selection , Liver Function , Tumor Board , Phase Iii Studies , Phase 3 Studies , Liver Directed Therapy , Open Label Phase Ii , High Afp ,

Anti-Angiogenic Systemic Therapies for Advanced HCC in Second Line and Beyond

Expert panelists highlight anti-angiogenic systemic therapies under investigation for advanced HCC in second line and beyond. ....

Transforming Outcomes , Hepatocellular Carcinoma , Expert Insights , Applying Evidence , Angiogenic Systemic Therapies , Second Line , Intermediate Stage , Systemic Therapy , Bclc Stage B , Patient Selection , Liver Function , Tumor Board , Phase Iii Studies , Phase 3 Studies , Liver Directed Therapy , Open Label Phase Ii , High Afp ,

Systemic Immunotherapies for Advanced HCC in Second Line and Beyond

In the context of frontline treatment strategies in advanced HCC, expert oncologists review clinical research in systemic immunotherapy approaches. ....

Transforming Outcomes , Hepatocellular Carcinoma , Expert Insights , Applying Evidence , Second Line , Intermediate Stage , Systemic Therapy , Bclc Stage B , Patient Selection , Liver Function , Tumor Board , Phase Iii Studies , Phase 3 Studies , Liver Directed Therapy , Open Label Phase Ii , High Afp ,

Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR

- Updated Phase 3 SIERRA data to be presented in an oral presentation by Boglarka Gyurkocza, M.D., SIERRA trial investigator from Memorial Sloan Kettering. ....

United States , Salt Lake City , Salt Palace Convention Center , Hans Vitzthum , Boglarka Gyurkocza , Sandesh Seth , James Foran , Avinash Desai , Lifesci Advisors , University Of Texas Md Anderson Cancer Center , American Society For Transplantation , International Blood Marrow Transplant Research , Exchange Commission , Astellas Pharma Inc , Actinium Pharmaceuticals Inc , European Medicines Agency , Committee For Medicinal Products Human Use , Epicentrx Inc , Fred Hutchinson Cancer Research Center , Mayo Clinical Cancer Center , Memorial Sloan Kettering Cancer Center , Memorial Sloan Kettering Cancer , Patient Journey , Applying Evidence , Novel Therapeutics , Actinium Pharmaceuticals ,